GM
69
-3
DE
46
-3
CI
45
5
VRTX
45
2
MO
57
3
COF
48
-2
NWS
84
20
FRT
51
-2
NWL
33
-2
HST
37
-2
KEY
58
-2
NEM
57
2
EXPE
61
2
NKE
28
-3
VRSN
53
-11
MET
61
-2
DVN
27
2
COST
45
-3
AZO
63
-2
LNC
52
9
GM
69
-3
DE
46
-3
CI
45
5
VRTX
45
2
MO
57
3
COF
48
-2
NWS
84
20
FRT
51
-2
NWL
33
-2
HST
37
-2
KEY
58
-2
NEM
57
2
EXPE
61
2
NKE
28
-3
VRSN
53
-11
MET
61
-2
DVN
27
2
COST
45
-3
AZO
63
-2
LNC
52
9
Financhill
Back

TransMedics Group Stock Predictions

Pacaso, now reserving Nasdaq ticker PCSO, is offering shares at $2.80 until May 29.

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.*Pacaso recently received their ticker reservation with Nasdaq
Buy
80

TMDX
TransMedics Group

Last Price:
$124.22
Seasonality Move:
18.31%

7 Day Trial

ALL ACCESS PASS

$ 7

Could BOXABL Be the Tesla of Housing?

Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.

TransMedics Group Stock Forecast

  • Over the next 52 weeks, TransMedics Group has on average historically risen by 59.7% based on the past 6 years of stock performance.
  • TransMedics Group has risen higher in 4 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
  • Is TransMedics Group Stock Undervalued?
    The current TransMedics Group [TMDX] share price is $124.25. The Score for TMDX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • TMDX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.

Will TransMedics Group Stock Go Up Next Year?

  • Over the next 52 weeks, TransMedics Group has on average historically risen by 59.7% based on the past 6 years of stock performance.

TransMedics Group Stock Rating

Buy
80
TransMedics Group (TMDX) is a Buy

Is TransMedics Group overpriced?

  • TransMedics Group has risen higher in 4 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

TransMedics Group Stock Price History

Is TMDX stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TMDX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Health Care Equipment & Supplies
Sector:
Health Care
Type:
stock
Website:
transmedics.com

52-Week Data

52-Week High:
177.37
52-Week Low:
55.00

Prediction Charts

Market Cap:
4.2B
Price in USD:
124.25
Volume:
445.1K
Beta:
1.96

Technical Analysis

SMA50:
89.04
SMA100:
78.48
SMA200:
99.62
52-Wk Change:
-9.66%

Stock Predictions

  • Is TransMedics Group stock public?
    Yes, TransMedics Group is a publicly traded company.
  • What is the TransMedics Group stock quote today?
    The TransMedics Group stock price is 124.25 USD today.
  • How to buy TransMedics Group stock online?
    You can buy TransMedics Group shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-6 91.59 93.38 94.03 91.01
May-7 94.00 95.81 96.73 93.11
May-8 96.94 93.20 98.55 92.49
May-9 114.60 111.50 120.93 108.84
May-12 114.32 118.73 119.20 110.08
May-13 118.73 122.11 122.77 116.44
May-14 122.33 122.36 124.75 120.19
May-15 121.83 121.81 122.56 117.68
May-16 122.00 121.58 123.00 120.03
May-19 118.49 122.10 122.41 118.07
May-20 122.72 124.71 124.84 120.83
May-21 124.71 121.31 125.00 120.83
May-22 118.79 123.34 124.14 118.79
May-23 121.93 124.25 124.60 121.92

TransMedics Group Earnings

TransMedics Group Earnings Report: Per Share TransMedics Group Earnings Q1 Q2 Q3 and Q4 last year and next year.

TransMedics Group Forecast Revenue Growth

TransMedics Group Stock Analysis: Historical quarterly revenues per share for TransMedics Group and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.36 per share, an increase this year of $0.83 per share, and an increase next year of $0.69 per share.

* TransMedics Group stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.